Ryman Hospitality Properties, Inc. Reports First Quarter 2017 Results
May 02, 2017 12:32 pm UTC| Business
– RevPAR Increased 7.6%, Total RevPAR Increased 5.0% Compared to First Quarter 2016 – – Net Income Increased 23.8% to $32.6 Million Compared to First Quarter 2016 – – Total Adjusted EBITDA Increased 9.7% to $80.6...
Core-Mark Announces First Quarter 2017 Investor Call
May 02, 2017 12:31 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 02, 2017 -- Core-Mark Holding Company, Inc. (NASDAQ:CORE) announced today that it will release its earnings before the market opens on Tuesday May 9, 2017 for the first quarter ended...
Core-Mark Announces First Quarter 2017 Investor Call
May 02, 2017 12:31 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 02, 2017 -- Core-Mark Holding Company, Inc. (NASDAQ:CORE) announced today that it will release its earnings before the market opens on Tuesday May 9, 2017 for the first quarter ended...
Expeditors Reports First Quarter 2017 EPS of $0.51
May 02, 2017 12:31 pm UTC| Business
SEATTLE, May 02, 2017 -- Expeditors International of Washington, Inc. (NASDAQ:EXPD) today announced first quarter 2017 financial results including the following highlights compared to the same quarter of 2016: Diluted...
Expeditors Reports First Quarter 2017 EPS of $0.51
May 02, 2017 12:31 pm UTC| Business
SEATTLE, May 02, 2017 -- Expeditors International of Washington, Inc. (NASDAQ:EXPD) today announced first quarter 2017 financial results including the following highlights compared to the same quarter of 2016: Diluted...
May 02, 2017 12:31 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 02, 2017 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...
May 02, 2017 12:31 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 02, 2017 -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases,...